The present application relates to a pharmaceutical composition for use in the treatment of a wound infected with S. aureus to reduce scarring comprising digestive enzymes comprising protease, amylase, and lipase. The application further relates to a pharmaceutical composition for use in prophylactic wound treatment to prevent S. aureus infection comprising digestive enzymes comprising protease, amylase, and lipase.